Heart Attack Diagnostics Market: Global Trends, Growth Opportunities, and Industry Outlook
The Heart Attack Diagnostics Market is expanding as healthcare systems increasingly focus on early detection, rapid diagnosis, and effective monitoring of cardiovascular conditions.
According to Market Research Future, the global market was valued at USD 13.55 billion in 2025 and is projected to reach USD 32.25 billion by 2035, registering a CAGR of 9.1% during the forecast period.
The market includes diagnostic technologies such as electrocardiograms (ECG), blood tests, imaging tests, and echocardiography. Blood tests represented the largest test segment in 2025, supported by widespread adoption of high-sensitivity troponin testing.
Hospitals remain the leading end-user segment, accounting for 51.1% of global revenue in 2025. At the same time, home-based and tele-cardiology services are emerging rapidly as remote monitoring and connected healthcare technologies gain adoption.
North America held the largest regional share at 32.9% in 2025, while Asia-Pacific is expected to register the fastest growth, supported by expanding healthcare infrastructure, cardiovascular screening initiatives, and adoption of point-of-care diagnostic technologies.